incretin and glp 1 The mechanisms of dual receptor agonists. Glucagon-like incretin and glp 1 Targeting

With increasing clinical evidence, GLP-1RAs are set to become essential in treating complex and chronic diseases, offering significant health benefits and addressing unmet medical needs, thus enhancing patient quality of life and solidifying their role in future medical advancements

ISSN 1553-7374

has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen

Propionyl-L-carnitine is particularly effective for heart conditions, supporting circulation and exercise capacity

When using GLP-1 medications, certain foods and eating habits should be minimized or avoided because they may reduce treatment benefits, increase side effects, contribute to poor nutrition, interfere with blood sugar control, or affect healthy weight reduction

Topical calcineurin inhibitors for atopic dermatitis: Review and treatment recommendations